What are the primary types of laryngeal lymphoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Primary Types of Laryngeal Lymphoma

Primary laryngeal lymphoma is an extremely rare extranodal malignancy accounting for less than 1% of all primary laryngeal neoplasms, with diffuse large B-cell lymphoma (DLBCL) being the most common histologic subtype, followed by extranodal NK/T-cell lymphoma (nasal-type) and MALT-type marginal zone B-cell lymphoma. 1, 2, 3

Most Common Histologic Types

Diffuse Large B-Cell Lymphoma (DLBCL)

  • DLBCL represents the predominant histologic subtype of primary laryngeal lymphoma in reported cases 1, 2, 4
  • The tumor cells are CD20-positive, which is present in 86-100% of cases 5, 2
  • Immunophenotyping typically shows positivity for PAX5, BCL2, BCL6, and MUM1, with variable expression of CD10 4
  • DLBCL can present with unusual manifestations including laryngeal stenosis, subglottic involvement, or even tracheal fistula formation 6, 4

Extranodal NK/T-Cell Lymphoma, Nasal-Type

  • This represents an extremely aggressive subtype that rarely involves the larynx, with most cases occurring in the nasal cavity 3
  • The typical immunophenotype includes CD20-, CD2+, cytoplasmic CD3ε+ (surface CD3-), CD56+, with EBV-EBER positivity 7, 3
  • Cytotoxic granule proteins (TIA1, perforin, granzyme B) are usually expressed 7
  • Primary laryngeal involvement carries a poor prognosis even when diagnosed in localized stages, with rapid progression despite initial chemotherapy response 3

MALT-Type Marginal Zone B-Cell Lymphoma

  • MALT lymphoma represents one of the recognized but less common subtypes affecting the larynx 3
  • This indolent B-cell lymphoma accounts for 5% of all NHL cases in general populations 8

Rare Composite Presentations

Composite Lymphoma

  • The first reported case of primary laryngeal composite lymphoma consisted of both DLBCL and peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) occurring simultaneously 6
  • This extremely rare presentation can manifest with atypical clinical features including fistula formation, esophageal diverticulum, and neck abscess without a discrete mass 6

Critical Diagnostic Considerations

Biopsy Requirements

  • Excisional or incisional lymph node biopsy is mandatory for definitive diagnosis; fine needle aspiration is insufficient 8
  • Multiple deep biopsies may be required, as superficial laryngeal biopsies can show only crush artifacts or insufficient tissue 1, 4
  • In difficult cases, diagnosis may ultimately require biopsy of adjacent lymph nodes that appear weeks to months after initial presentation 1

Essential Immunophenotyping

  • All cases require comprehensive immunophenotyping to distinguish B-cell from T-cell/NK-cell lineage 9, 8
  • For B-cell lymphomas: CD20, CD19, PAX5, BCL2, BCL6, CD10, MUM1, cyclin D1, and kappa/lambda light chains 4
  • For T-cell/NK-cell lymphomas: CD3 (surface and cytoplasmic), CD2, CD4, CD5, CD7, CD8, CD56, TCRαβ, TCRγδ 7, 3
  • EBV-EBER in situ hybridization is critical for NK/T-cell lymphoma diagnosis 7, 3

References

Research

Primary laryngeal lymphoma: case report.

Ear, nose, & throat journal, 2006

Research

Primary laryngeal T/NK-cell lymphoma, nasal-type: an unusual location for an aggressive subtype of extranodal lymphoma.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2008

Guideline

Survival Odds for Pediatric Burkitt's Lymphoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

CD Markers for Natural Killer (NK) Cells

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lymphoma Classification and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.